#127 – What’s Pneu in Community-Acquired Pneumonia Part 2

#127 – What’s Pneu in Community-Acquired Pneumonia Part 2

Author: Society of Infectious Diseases Pharmacists November 28, 2025 Duration: 52:27

As promised, our host Dr, Ryan Moenster is back and breaking down the recently published ATS pneumonia guidelines — what’s pneu, what’s controversial, and what it means for your antimicrobial game! Dr. Whitney Hartlage (@whithartlage11) is back to join the conversation, plus fresh takes from Drs. Sharon Weissman and Sahil Angelo (@angelo_sahil).

References:

  1. Am J Respir Crit Care Med. 2025 Jul 18. doi: 10.1164/rccm.202507-1692ST. Online ahead of print.

  2. IDSA Sepsis Task Force. Infectious Diseases Society of America (IDSA) POSITION STATEMENT: Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines. Clin Infect Dis. 2018 May 2;66(10):1631-1635. doi: 10.1093/cid/cix997. PMID: 29182749; PMCID: PMC6927848.


Hosted by the Society of Infectious Diseases Pharmacists, Breakpoints is a podcast dedicated to the intricate and ever-evolving world of antimicrobial therapy. Each episode delves into the practical challenges and scientific nuances faced by pharmacists on the front lines of patient care, from interpreting susceptibility data and optimizing dosing strategies to navigating the complexities of antimicrobial stewardship. The conversations in this podcast bridge the gap between groundbreaking infectious diseases research and its direct application in clinical settings, offering insights that are both academically rigorous and immediately useful. You’ll hear expert discussions on new resistance patterns, evolving treatment guidelines, and the real-world implementation of life-saving protocols. Designed for healthcare professionals committed to precision medicine, Breakpoints provides a deeper understanding of how to effectively manage infections and improve patient outcomes. Tune in for thoughtful analysis and forward-thinking dialogue that defines the critical role of specialized pharmacists in public health.
Author: Language: en-us Episodes: 100

Breakpoints
Podcast Episodes
#62 – Novel TheraPOOtics: The Microbiome, C. difficile, and LBPs [not-audio_url] [/not-audio_url]

Duration: 47:08
In this spore-tacular episode of Breakpoints, Drs. Anne Gonzales-Luna (@anniejayTX) and Paul Feuerstadt (@DrPaulGastro) join Dr. Rachel Britt (@rachelbpharmd) to discuss the microbiome, its relationship to C. difficile,…
#61 – Dosing Consult: Linezolid Therapeutic Drug Monitoring [not-audio_url] [/not-audio_url]

Duration: 50:48
In the second episode of Breakpoints' Dosing Consult series, Drs. Ryan Crass (@crasspofungin) and Amit Pai (@DosingMatters) join Dr. Jillian Hayes (@thejillianhayes) to break down the 5 Ws and 1 H of linezolid TDM. Linke…
#59 – Resistance in Pseudomonas aeruginosa: Pearls and Perils [not-audio_url] [/not-audio_url]

Duration: 1:36:10
Drs. Antonio Oliver (@aoliverp73) and Maggie Monogue (@MaggieMonogue) join Dr. Erin McCreary (@Erin McCreary) to discuss all things Pseudomonas aeruginosa. Tune in to learn from some of the best about the complexities of…
#57 – Dosing Consult: Ceftriaxone [not-audio_url] [/not-audio_url]

Duration: 0:00
Drs. Tom Dilworth and Stephanie Shealy May (@stephshealymay) join Dr. Rachel Britt (@RachelBPharmD) in the first episode of Breakpoints Dosing Consults to discuss questions and debates around ceftriaxone dosing. When sho…
#55 – One World: Global Perspectives in Antimicrobial Stewardship [not-audio_url] [/not-audio_url]

Duration: 1:27:09
Drs. Debbie Goff (@idpharmd), Khalid Eljaaly (@khalideljaaly), and Angeliki Messina (@AngPharmID) join Dr. David Ha (@DHpharmd) as part of a global panel discussion on international antimicrobial stewardship practices. L…